Pharmacogenetics and medical practice
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: DURAND, Geneviève (Bichat Hospital, Paris, France)
Rapid advances in the understanding of genetic variation affecting drug responses and the development of new technologies (real-time PCR, DNA chips) are converging to envisage new in vitro diagnostic assays. Genetic factors modifying the pharmacokinetics and pharmacodynamics of drug reactions could explain the interindividual variation of drug.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.